Quantitative approach for incorporating methylmercury risks and omega-3 fatty acid benefits in developing species-specific fish consumption advice

Environmental Health Perspectives

Volumn 117, Issue 2, 2009, Pages 267-275

  Ginsberg, Gary L ^a   Toal, Brian F ^a  

^a CDC   (United States)

Author keywords

Cardiovascular risk; Fish advisory; Methylmercury; Neurodevelopment; Omega 3 fatty acids; Risk benefit

Indexed keywords

METHYLMERCURY; OMEGA 3 FATTY ACID;

ARTICLE; CANCER RISK; CANNED FOOD; CARDIOVASCULAR RISK; CONTROLLED STUDY; FISH; FLOUNDER; FOOD CONTAMINATION; FOOD INTAKE; HERRING; ISCHEMIC HEART DISEASE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK BENEFIT ANALYSIS; SALMON; SHARK; SPECIES DIFFERENCE; TROUT; TUNA;

ANIMALS; CARDIOVASCULAR SYSTEM; FATTY ACIDS, OMEGA-3; FISHES; HUMANS; METHYLMERCURY COMPOUNDS; NEUROGENESIS; RISK ASSESSMENT; SALMON; SHARKS; TROUT; TUNA;

CHONDRICHTHYES; CLUPEIDAE; PLEURONECTOIDEI; SALMONIDAE; SCOMBRIDAE; XIPHIAS GLADIUS;

EID: 60749084189     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11368     Document Type: Article

References (75)

1. Ahlqwist M, Bengtsson C, Lapidus L, Bergdahl IA, Schutz A. 1999. Serum mercury concentration in relation to survival, symptoms, and diseases: results from the prospective population study of women in Gothenburg, Sweden. Acta Odontol Scand 57:168-174.
2. American Heart Association. 2008. Fish, Levels of Mercury and Omega-3 Fatty Acids. Available: http://www.americanheart.org/ presenter.jhtml?identifier=3013797 [accessed 28 July 2008].
3. Andersen HR, Andersen O. 1993. Effects of dietary alphatocopherol and beta-carotene on lipid peroxidation induced by methyl mercuric chloride in mice. Pharmacol Toxicol 73:192-201.
4. ATSDR. 1999. Toxicological Profile for Mercury. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
5. Axelrad DA, Bellinger DC, Ryan LM, Woodruff TJ. 2007. Dose-response relationship of prenatal mercury exposure and IQ: an integrative analysis of epidemiologic data. Environ Health Perspect 115:609-615.
6. Barre DE. 2007. The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes - a mini-review. J Oleo Sci 56:319-325.
7. Bocio A, Domingo JL, Falco G, Llobet JM. 2007. Concentrations of PCDD/ PCDFs and PCBs in fish and seafood from the Catalan (Spain) market: estimated human intake. Environ Int 33:170-175.
8. Boffetta P, Sallsten G, Garcia-Gomez M, Pompe-Kirn V, Zaridze D, Bulbulyan M, et al. 2001. Mortality from cardiovascular diseases and exposure to inorganic mercury. Occup Environ Med 58:461-466.
9. Bousquet M, Saint-Pierre M, Julien C, Salem N, Cicchetti F, Calon F. 2008. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J 22(4):1213-1225.
10. Burger J, Stern AH, Gochfeld M. 2005. Mercury in commercial fish: optimizing individual choices to reduce risk. Environ Health Perspect 113:266-271.
11. Calon F, Cole G. 2007. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases. Evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids 77:287-293.
12. Carrington CD, Bolger MP. 2002. An exposure assessment for methylmercury from seafood for consumers in the United States. Risk Anal 22:689-699.
13. Cohen JT, Bellinger DC, Connor WE, Kris-Etherton PM, Lawrence RS, Savitz DA, et al. 2005a. A quantitative risk-benefit analysis of changes in population fish consumption. Am J Prev Med 29:325-334.
14. Cohen JT, Bellinger DC, Connor WE, Shaywitz BA. 2005b. A quantitative analysis of pre-natal intake of n-3 polyunsaturated fatty acids and cognitive development. Am J Prev Med 29:366-374.
15. Cohen JT, Bellinger DC, Shaywitz BA. 2005c. A quantitative analysis of pre-natal methyl mercury exposure and cognitive development. Am J Prev Med 29:353-365.
16. Connor WE. 2000. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71(1 suppl):171S-175S.
17. Couzin J. 2007. Dietary guidelines spark flap over fish consumption. Science 318:550-551.
18. Daniels JL, Longnecker MP, Rowland AS, Golding J. 2004. Fish intake during pregnancy and early cognitive development of offspring. Epidemiology 15:394-402.
19. Davidson PW, Myers GJ, Cox C, Axtell C, Shamlaye C, Sloane-Reeves J, et al. 1998. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles child development study. JAMA 280:701-707.
20. Davidson PW, Myers GJ, Weiss B, Shamlaye CF, Cox C. 2006. Prenatal methyl mercury exposure from fish consumption and child development: a review of evidence and perspectives from the Seychelles Child Development Study. Neurotoxicology 27:1106-1109.
21. Domingo JL, Bocio A, Falco G, Llobet JM. 2007a. Benefits and risks of fish consumption. Part I. A quantitative analysis of the intake of omega-3 fatty acids and chemical contaminants. Toxicology 230:219-226.
22. Domingo JL, Bocio A, Marti-Cid R, Llobet JM. 2007b. Benefits and risks of fish consumption. Part II. RIBEPEIX, a computer program to optimize the balance between the intake of omega-3 fatty acids and chemical contaminants. Toxicology 230:227-233.
23. Farooqui AA, Ong WY, Horrocks LA, Chen P, Farooqui T. 2007. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Brain Res Rev 56:443-471.
24. FDA (Food and Drug Administration). 2004. Press Release: FDA and EPA Announce the Revised Consumer Advisory on Methylmercury in Fish, March 19, 2004. Available: http://www.fda.gov/bbs/topics/news/2004/ NEW01038.html [accessed 7 January 2009].
25. FDA. 2005. Letter Regarding Eggs with Enhanced Omega-3 Fatty Acid Content and a Balanced Ratio of Omega-3/Omega-6 Fatty Acids and Reduced Risk of Heart Disease and Sudden Fatal Heart Attack (Docket No. 2004Q-0072). Available: http://www.cfsan.fda.gov/~dms/qhceggs.html [accessed 6 January 2009].
26. FDA. 2006. Mercury Levels in Commercial Fish and Shellfish. Available: http://www.cfsan.fda.gov/~frf/sea-mehg.html [accessed 10 July 2008].
27. Fleith M, Clandinin MT. 2005. Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev Food Sci Nutr 45:205-229.
28. Foran JA, Carpenter DO, Hamilton MC, Knuth BA, Schwager SJ. 2005. Risk-based consumption advice for farmed Atlantic and wild Pacific salmon contaminated with dioxins and dioxin-like compounds. Environ Health Perspect 113:552-556.
29. Ginsberg GL, Toal BF. 2000. Development of a single meal fish consumption advisory for methyl mercury. Risk Anal 20:41-47.
30. Grandjean P, Weihe P, White RF, Debes F, Arak S, Yokoyama K, et al. 1997. Cognitive deficit in 7 year old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 19:417-428.
31. Guallar E, Sanz-Gallardo MI, van't Veer P, Bode P, Aro A, Gomez-Aracena J, et al. 2002. Heavy metals and myocardial infarction study group. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 347:1747-1754.
32. Hagele TJ, Mazerik JN, Gregory A, Kaufman B, Magalang U, Kuppusamy ML. 2007. Mercury activates vascular endothelial cell phospholipase D through thiols and oxidative stress. Int J Toxicol 26:57-69.
33. Hallgren CG, Hallmans G, Jansson J-H, Marklund SL, Huhtasaari F, Schutz A. 2001. Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br J Nutr 86:397-404.
34. Hibbeln JR, Davis JM, Steer C, Emmett P, Rogers I, Williams C, et al. 2007. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 369:578-585.
35. Hites RA, Foran JA, Carpenter DO, Hamilton MC, Knuth BA, Schwager SJ. 2004. Global assessment of organic contaminants in farmed salmon. Science 303:226-229.
36. Hobson K. 2006. Diet, Fitness, and Exercise: Two Reports Offer Guidance on Eating Fish. Available: http://health.usnews. com/usnews/health/ articles/061019/19fish.htm [accessed 6 January 2009].
37. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, et al. 2006. Risks and benefits of omega 3 fats for mortality, cardiovascular disease and cancer: systematic review. Br Med J 332:752-760.
38. Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A, et al. 2006. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci USA 103:11276-11281.
39. IOM (Institute of Medicine). 2006. Seafood Choices: Balancing Benefits and Risks. Washington, DC:National Academy Press.
40. Kjellstrom T, Kennedy P, Wallis S, Stewart A, Friberg L, Lind B, et al. 1989. Physical and Mental Development of Children with Prenatal Exposure to Mercury from Fish. Report No. 3642. Solna, Sweden:National Swedish Environmental Protection Board.
41. Konig A, Bouzan C, Cohen JT, Conno WE, Kris-Etherton PM, Gray GM, et al. 2005. A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med 29:335-346.
42. Kremer JM. 2000. n-3 Fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr 71(suppl 1):349S-351S.
43. Mahaffey KR, Clickner RP, Jeffries RA. 2007. Methyl mercury and omega-3 fatty acids: co-occurrence of dietary sources with emphasis on fish and shellfish. Environ Res 107:20-29.
44. Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, et al. 2006. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci USA 103:15184-15189.
45. Mazerik JN, Hagele T, Sherwani S, Ciapala V, Butler S, Kuppusamy ML, et al. 2007. Phospholipase A2 activation regulates cytotoxicity of methylmercury in vascular endothelial cells. Int J Toxicol 26:553-569.
46. McCann P. 2005. Great Lakes Mercury Protocol. In: Proceedings of the 2005 National Forum on Contaminants in Fish. U.S. EPA 823-R-05-006. Washington, DC:U.S. Environmental Protection Agency. Available: http://epa.gov/waterscience/fish/forum/2005/proceedings2005.pdf [accessed 6 January 2009].
47. McNutt L-A, Wu C, Xue X, Hafner JP. 2003. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157:940-943.
48. Mozaffarian D, Rimm EB. 2006. Fish intake, contaminants, and human health. Evaluating the risks and benefits. JAMA 296:1885-1899.
49. NRC (National Research Council). 2000. Toxicological Effects of Methyl Mercury. Washington, DC:National Academy Press.
50. Ohno T, Sakamoto M, Kurosawa T, Dakeishi M, Iwata T, Murata K. 2007. Total mercury levels in hair, toenail, and urine among women free from occupational exposure and their relations to renal tubular function. Environ Res 103:191-197.
51. Oken E, Kleinman KP, Berland WE, Simon SR, Rich-Edwards JW, Gillman MW. 2003. Decline in fish consumption among pregnant women after a national mercury advisory. Obstet Gynecol 102:346-351.
52. Oken E, Radesky JS, Wright RO, Bellinger DC, Amarasiriwardena CJ, Kleinman KP, et al. 2008. Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am J Epidemiol 167:1171-1181.
53. Oken E, Wright RO, Kleinman KP, Bellinger D, Amarasiriwardena CJ, Hu H, et al. 2005. Maternal fish consumption, hair mercury and infant cognition in a U.S. cohort. Environ Health Perspect 113:1376-1380.
54. Ponce RA, Bartell SM, Wong EY, LaFlamme D, Carrington C, Lee RC, et al. 2000. Use of quality-adjusted life year weights with dose-response models for public health decisions: a case study of the risks and benefits of fish consumption. Risk Anal 20:529-542.
55. Racine RA, Deckelbaum RJ. 2007. Sources of the very-longchain unsaturated omega-3 fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Curr Opin Clin Nutr Metab Care 10:123-128.
56. Rice DC, Schoeny R, Mahaffey K. 2003. Methods and rationale for derivation of a reference dose for methylmercury by the U.S. EPA. Risk Anal 23:107-115.
57. Rissanen T, Voutilainen S, Nyyssonen K, Lakka TA, SalonenJT. 2000. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events. The Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation 102:2677-2679.
58. Rose SA, Feldman JF. 1995. Prediction of IQ and specific cognitive abilities at 11 years from infancy measures. Dev Psychol 31:685-696.
59. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. 2000. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4 year follow-up study in men in eastern Finland. Atherosclerosis 148:265-273.
60. Salonen JT, Seppanen K, Nyyssonen K, Korpela H, KauhanenJ, Kantola M, et al. 1995. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 91:645-655.
61. SanGiovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL III, Gensler GR, et al. 2007. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS report no. 20. Arch Ophthalmol 125:671-679.
62. Stern AH. 2005. A review of the studies of the cardiovascular health effects of methylmercury with consideration of their suitability for risk assessment. Environ Res 98:133-142.
63. Stern AH. 2007. Public health guidance on cardiovascular benefits and risks related to fish consumption. Environ Health 6:31; doi:10.1186/ 1476-069X-6-31 [Online 23 October 2007].
64. Uauy R, Hoffman DR, Mena P, Llanos A, Birch EE. 2003. Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials. J Pediatr 143:S17-S25.
65. USDA. 2005. Addendum A: EPA and DHA Content of Fish Species. Available: http://www.health.gov/dietaryguidelines/dga2005/report/HTML/ table_g2_adda2.htm [accessed 10 July 2008].
66. U.S. EPA (U.S. Environmental Protection Agency). 1995. IRIS file for Mercuric Chloride. Available: http://www.epa.gov/ncea/iris/subst/ 0692.htm [accessed 7 January 2009].
67. U.S. EPA (U.S. Environmental Protection Agency). 2001. Methylmercury (MeHg) (CASRN 22967-92-6). Available: http://www.epa.gov/iris/subst/ 0073.htm [accessed 7 January 2009].
68. U.S. EPA (U.S. Environmental Protection Agency). 2004. What You Need to Know about Mercury in Fish and Shellfish. Available: http://www.epa.gov/ waterscience/fishadvice/advice.html [accessed 10 July 2008].
69. Virtanen JK, Voutilainen S, Rissanen TH, Mursu J, TuomainenT-P, Korhonen MJ, et al. 2005. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol 25:228-233.
70. Von Schacky C. 2007. Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care 10:129-135.
71. Wakita Y. 1987. Hypertension caused by methyl mercury in rats. Toxicol Appl Pharmacol 89:144-147.
72. World Health Organization. 1998. Assessment of the Health Risk of Dioxins: Re-evaluation of the Tolerable Daily Intake (TDI). Geneva:World Health Organization, European Centre for Environment and Health, and International Programme on Chemical Safety.
73. Yoshizawa K, Rimm EB, Morris JS, Spate VL, Hsieh C-C, Spiegelman D, et al. 2002. Mercury and the risk of coronary heart disease in men. N Engl J Med 347:1755-1760.
74. Young G, Conquer J. 2005. Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 45:1-28.
75. Zhang J, Yu KF. 1998. What's relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280:1690-1691.